Clinical Trial Update: A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety, efficacy, and pharmacokinetic study of siltuximab in patients with various solid tumors has been completed, including ovarian, pancreatic, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Siltuximab (siltuximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Ovarian Neoplasms, Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED